Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYCR1 | P32322 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.36 |
| ▸ | MAOB | P27338 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12073330 | 0.87 | — | — | |
| SCHEMBL468463 | 0.84 | KDM4E (0.34) | PYCR1CHRM1CHRM2CHRM4CHRM5 | |
| SCHEMBL4370427 | 0.80 | MAOB (0.39) | PYCR1MAOBKDM4EALDH1A1HPGD | |
| SCHEMBL3177965 | 0.79 | MGAM (0.41) | PYCR1 | |
| SCHEMBL3178805 | 0.76 | CA12 (0.41) | ALDH1A1 | |
| SCHEMBL24404196 | 0.76 | CHRM1 (0.44) | PYCR1CHRM1CHRM2CHRM4CHRM5 | |
| SCHEMBL1245328 | 0.76 | — | — | |
| SCHEMBL9215139 | 0.76 | — | — | |
| SCHEMBL3167085 | 0.74 | TSHR (0.34) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| SCHEMBL3161150 | 0.74 | KCNQ4 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6607868-B2 | Dipropargyl acetamide | HYNIX SEMICONDUCTOR INC. (KR) | 2003-08-19 | — | — | US | claimed |
| US-20020012879-A1 | Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same | HYNIX SEMICONDUCTOR INC. (KR) | 2002-01-31 | — | — | US | claimed |
| US-6607868-B2 | Dipropargyl acetamide | HYNIX SEMICONDUCTOR INC. (KR) | 2003-08-19 | — | — | US | disclosed |
| US-6607868-B2 | Dipropargyl acetamide | HYNIX SEMICONDUCTOR INC. (KR) | 2003-08-19 | — | — | US | disclosed |
| US-20020012879-A1 | Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same | HYNIX SEMICONDUCTOR INC. (KR) | 2002-01-31 | — | — | US | disclosed |
| US-20020012879-A1 | Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same | HYNIX SEMICONDUCTOR INC. (KR) | 2002-01-31 | — | — | US | disclosed |
| CN-86102450-A | The method for preparing heterogeneous ring compound | — | 1987-02-18 | — | — | CN | disclosed |
| US-4567298-A | ELECTROCONDUCTIVITY | W. R. GRACE & CO. (US) | 1986-01-28 | — | — | US | disclosed |
| US-4511702-A | ELECTROCONDUCTIVITY | W. R. GRACE & CO. (US) | 1985-04-16 | — | — | US | disclosed |
| US-4497727-A | Poly(dipropargylamine)and derivatives thereof per se and _p-doped and processes for preparing same | W. R. GRACE & CO. (US) | 1985-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020012879-A1 | Novel photoresist monomers, polymers thereof, and photoresist compositions containing the same | CDH1, DDAH1, DPEP1 | PYCR1 226/4885CHRM1 1434/4885CHRM2 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.